Nocion Therapeutics is revolutionizing the treatment of neurogenic inflammation by silencing inflamed nociceptors.
Location: United States, Massachusetts, Cambridge
Total raised: $89M
Investors 4
| Date | Name | Website |
| - | Mission Bi... | missionbio... |
| - | F-Prime Ca... | fprimecapi... |
| - | Canaan Par... | canaan.com |
| - | Eight Road... | eightroads... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.03.2024 | Series B | $62M | - |
| 20.04.2019 | Series A | $27M | Canaan Par... |
Mentions in press and media 18
| Date | Title | Description |
| 08.01.2026 | Nocion Therapeutics Extends Series B Financing to $93M | Nocion Therapeutics, Inc., a Watertown, MA-based biopharmaceutical company, raised $23M from existing investors in an extension of its Series B funding. The raise brought the total amount of the Series B financing to $93M. The company inten... |
| 02.04.2024 | Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment | TORONTO, ON / ACCESSWIRE / APRIL 2, 2024 / Lumira Ventures is delighted to announce its latest investment in Nocion Therapeutics, a clinical-stage biopharmaceutical company developing first and potentially best-in-class, small molecule char... |
| 07.03.2024 | Nocion Therapeutics Raises $62 Million for Innovative Treatment Development | WATERTOWN, MA - Nocion Therapeutics, a cutting-edge biopharmaceutical company, secures $62 million in Series B funding to propel their groundbreaking treatment development. Nocion's focus lies in creating small molecule sodium channel block... |
| 06.03.2024 | Nocion Therapeutics Raises $62M in Series B Financing | Nocion Therapeutics, a Watertown, MA-based clinical-stage biopharmaceutical company, raised $62M in Series B funding. The round, which brought the total amount to $122M, was led by Arkin Bio Capital and Monograph Capital with participation ... |
| 04.03.2024 | Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development | - |
| 04.03.2024 | Nocion Therapeutics Announces $62 Million Series B | WATERTOWN, MA, Nocion Therapeutics, a clinical-stage biopharmaceutical company, announced that it has raised $62 million in Series B funding. >> Click here for more funding data on Nocion Therapeutics >> To export Nocion The... |
| 22.04.2019 | Vaping Startup Pax Labs Raises $420 Million in Funding: Term Sheet for Monday, April 22 | A UNICORN THAT VAPES We’ve got another vaping unicorn. Paid Content You can't secure what you can't see From ExtraHop You may wonder — is e-cigarette vaping startup Juul somehow involved in this? Not really, but it does have connections. Ju... |
| 20.04.2019 | Canaan Leads $27M Series A for Nocion Therapeutics | Cambridge, Massachusetts-based Nocion Therapeutics, a biopharmaceutical startup, has raised $27 million in Series A funding. F-Prime Capital Partners and Canaan led the round with participation from Partners Innovation Fund and BioInnovatio... |
| 19.04.2019 | Term Sheet — Friday, April 19 | SOARING “I have no idea why.” Paid Content Securing the enterprise without boundaries From ExtraHop Asked whether Zoom had left money on the table by pricing its shares too low, Yuan said that Wall Street’s reaction was “out of our control.... |
| 18.04.2019 | Nocion Therapeutics Raises $27M in Series A Funding | Nocion Therapeutics, a Cambridge, MA–based company targeting neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids, raised $27M in Series A funding. The round was led by F-Prime Capital Partners an... |
Show more